	US 12,329,798 B2
	Composition for preventing or treating hypertension
Hobin Moon, Seoul (KR); Doo Suk Lee, Gyeonggi-do (KR); Wonwoo Lee, Seoul (KR); and Seunghwan Son, Seoul (KR)
Assigned to Hobin Moon, Seoul (KR)
Appl. No. 17/779,680
Filed by Hobin Moon, Seoul (KR)
PCT Filed Nov. 27, 2020, PCT No. PCT/KR2020/017187 § 371(c)(1), (2) Date May 25, 2022, PCT Pub. No. WO2021/107719, PCT Pub. Date Jun. 3, 2021.
Claims priority of application No. 10-2019-0157657 (KR), filed on Nov. 29, 2019.
Prior Publication US 2022/0401503 A1, Dec. 22, 2022
Int. Cl. A61K 36/488 (2006.01); A61K 36/346 (2006.01); A61K 36/79 (2006.01); A61K 36/8945 (2006.01); A61K 36/8968 (2006.01); A61K 36/8994 (2006.01); A61P 9/12 (2006.01)

CPC A61K 36/488 (2013.01) [A61K 36/346 (2013.01); A61K 36/79 (2013.01); A61K 36/8945 (2013.01); A61K 36/8968 (2013.01); A61K 36/8994 (2013.01); A61P 9/12 (2018.01); A61K 2236/331 (2013.01); A61K 2236/333 (2013.01)]

5 Claims

1. A method for prevention, alleviation, or treatment of hypertension or a hypertension-related disease comprising:

administering a composition to a subject in need thereof, the composition comprising a complex extract of Puerariae Radix, Platycodonis Radix, Liriopis Tuber, Dioscoreae Rhizoma, Coicis Semen, and Schisandrae Fructus, wherein the mixing weight ratio of Puerariae Radix, Platycodonis Radix, Liriopis Tuber, Dioscoreae Rhizoma, Coicis Semen, and Schisandrae Fructus in the complex extract is 2:2:2:1:1:1.